Capital Market Strategies’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $320K | Sell |
2,529
-195
| -7% | -$24.7K | 0.22% | 93 |
|
|
2025
Q1 | $348K | Hold |
2,724
| – | – | 0.23% | 87 |
|
|
2024
Q4 | $360K | Sell |
2,724
-3
| -0.1% | -$397 | 0.21% | 103 |
|
|
2024
Q3 | $397K | Hold |
2,727
| – | – | 0.24% | 84 |
|
|
2024
Q2 | $374K | Buy |
2,727
+450
| +20% | +$61.8K | 0.24% | 85 |
|
|
2024
Q1 | $312K | Sell |
2,277
-112
| -5% | -$15.4K | 0.24% | 95 |
|
|
2023
Q4 | $325K | Sell |
2,389
-150
| -6% | -$20.4K | 0.28% | 85 |
|
|
2023
Q3 | $303K | Sell |
2,539
-100
| -4% | -$11.9K | 0.3% | 83 |
|
|
2023
Q2 | $335K | Buy |
+2,639
| New | +$335K | 0.31% | 82 |
|
|
2023
Q1 | – | Sell |
-2,618
| Closed | -$344K | – | 79 |
|
|
2022
Q4 | $344K | Sell |
2,618
-2
| -0.1% | -$263 | 0.37% | 74 |
|
|
2022
Q3 | $306K | Sell |
2,620
-50
| -2% | -$5.84K | 0.34% | 85 |
|
|
2022
Q2 | $314K | Hold |
2,670
| – | – | 0.33% | 88 |
|
|
2022
Q1 | $348K | Sell |
2,670
-374
| -12% | -$48.7K | 0.3% | 91 |
|
|
2021
Q4 | $465K | Buy |
+3,044
| New | +$465K | 0.38% | 70 |
|